Want to join the conversation?
$WRK's 4Q15 earnings declined 58% to $0.44 per diluted share and net income fell 25% to $115.8MM from a year ago, hurt by $112MM of pre-tax restructuring and other costs. Its revenues also fell 5% YoverY to $3.87Bil, which is partly attributable to FX impact of $141MM and lower revenue after the sale of MWV European tobacco business of $44MM.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.